Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04068155 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of of Malignant Cutaneous Tumors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 2025 to Jan 2027
    • Study completion date: Jan 2025 to Jan 2028
    • Study title expanded, about 1 word
    v14
  2. Re-verified, no change to tracked fieldsv13
  3. Primary and study completion dates: Jan 2024 to Jan 2025v12
  4. Re-verified, no change to tracked fieldsv11
  5. Study sites: 1 to 2v10
Show 8 earlier versionsHide 8 earlier versions
  1. 2 versions Re-verified since May 23, 2022, no change to tracked fieldsv8-v9
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2022 to Apr 1, 2022
    v7
  3. Primary and study completion dates: Jan 2023 to Jan 2024
    • Start date: Oct 2021 to Jun 2022
    v6
  4. Start date: Apr 2021 to Oct 2021v5
  5. Start date: Oct 2020 to Apr 2021v4
  6. Start date: Jan 2020 to Oct 2020v3
  7. Start date: Nov 2019 to Jan 2020
    • Primary and study completion dates: Nov 2022 to Jan 2023
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for Malignant Cutaneous Tumors
Trial Details
NCT Number NCT04068155
Lead Sponsor Alpha Tau Medical LTD.
Conditions
(from sponsor)		 Skin Cancer, Cutaneous Tumor, Cutaneous Metastasis
Related terms Basal Cell Carcinoma, Carcinoma, Squamous Cell, Eyelid Neoplasms, Lip Neoplasms, Skin Neoplasms
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov